{
  "id": "54ede5c394afd61504000006",
  "type": "yesno",
  "question": "Is Fanconi anemia presented as a genetically and clinically heterogeneous disease entity?",
  "ideal_answer": "Fanconi anemia (FA), an autosomal recessive disorder characterized by a progressive pancytopenia associated with congenital anomalies and high predisposition to malignancies, is a genetically and clinically heterogeneous disease. At least eight complementation groups (FA-A to FA-H) have been identified  ",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/21956823",
    "http://www.ncbi.nlm.nih.gov/pubmed/12955722",
    "http://www.ncbi.nlm.nih.gov/pubmed/9521584",
    "http://www.ncbi.nlm.nih.gov/pubmed/10090479",
    "http://www.ncbi.nlm.nih.gov/pubmed/12552564",
    "http://www.ncbi.nlm.nih.gov/pubmed/23146055",
    "http://www.ncbi.nlm.nih.gov/pubmed/20453460",
    "http://www.ncbi.nlm.nih.gov/pubmed/20089964",
    "http://www.ncbi.nlm.nih.gov/pubmed/24604962",
    "http://www.ncbi.nlm.nih.gov/pubmed/9565158",
    "http://www.ncbi.nlm.nih.gov/pubmed/19264559",
    "http://www.ncbi.nlm.nih.gov/pubmed/11110674",
    "http://www.ncbi.nlm.nih.gov/pubmed/25002988",
    "http://www.ncbi.nlm.nih.gov/pubmed/10807541",
    "http://www.ncbi.nlm.nih.gov/pubmed/15453041",
    "http://www.ncbi.nlm.nih.gov/pubmed/19367192",
    "http://www.ncbi.nlm.nih.gov/pubmed/22480464",
    "http://www.ncbi.nlm.nih.gov/pubmed/11091222",
    "http://www.ncbi.nlm.nih.gov/pubmed/16238440",
    "http://www.ncbi.nlm.nih.gov/pubmed/12389351",
    "http://www.ncbi.nlm.nih.gov/pubmed/15657175",
    "http://www.ncbi.nlm.nih.gov/pubmed/12827451",
    "http://www.ncbi.nlm.nih.gov/pubmed/9721219",
    "http://www.ncbi.nlm.nih.gov/pubmed/21438918"
  ],
  "snippets": [
    {
      "text": "Fanconi anaemia (FA) is a rare, autosomal recessive, genetically complex, DNA repair deficiency syndrome in man. Patients with FA exhibit a heterogeneous spectrum of clinical features. The most significant and consistent phenotypic characteristics are stem cell loss, causing progressive bone marrow failure and sterility, diverse developmental abnormalities and a profound predisposition to neoplasia. To date, 15 genes have been identified, biallelic disruption of any one of which results in this clinically defined syndrome",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21956823",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a clinically and genetically heterogeneous disorder",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11110674",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Significant phenotypic differences were found. FA-G patients had more severe cytopenia and a higher incidence of leukemia. Somatic abnormalities were less prevalent in FA-C, but more common in the rare groups FA-D, FA-E, and FA-F. In FA-A, patients homozygous for null mutations had an earlier onset of anemia and a higher incidence of leukemia than those with mutations producing an altered protein",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11110674",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA), an autosomal recessive disorder characterized by a progressive pancytopenia associated with congenital anomalies and high predisposition to malignancies, is a genetically and clinically heterogeneous disease. At least eight complementation groups (FA-A to FA-H) have been identified",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10807541",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA), an autosomal recessive disorder characterized by a progressive pancytopenia associated with congenital anomalies and high predisposition to malignancies, is a genetically and clinically heterogeneous disease. At least eight complementation groups (FA-A to FA-H) have been identified with their relative prevalence varying among the ethnical backgrounds",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10090479",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia is a rare autosomal recessive disorder characterized clinically by congenital abnormalities, progressive bone marrow failure, and a predisposition to malignancy. FA cells are sensitive to DNA cross-linking agents. Complementation analysis of FA cells using somatic cell fusion has facilitated the identification of eight complementation groups, suggesting that FA is a genetically heterogeneous disorder. Six genes (FANCA, FANCC, FANCD2, FANCE, FANGF, FANCG) have been cloned so far",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12389351",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA), an autosomal recessive disorder characterized by a progressive pancytopenia associated with congenital anomalies and high predisposition to malignancies, is a genetically and clinically heterogeneous disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10807541",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA), an autosomal recessive disorder characterized by a progressive pancytopenia associated with congenital anomalies and high predisposition to malignancies, is a genetically and clinically heterogeneous disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10090479",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Among patients with bone marrow failure (BMF) syndrome, some are happened to have underlying Fanconi anemia (FA), a genetically heterogeneous disease, which is characterized by progressive pancytopenia and cancer susceptibility.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20453460",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a genetically and phenotypically heterogeneous inherited disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22480464",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia is a genetically heterogeneous recessive disease characterized mainly by bone marrow failure and cancer predisposition.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16238440",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Fanconi anemia (FA) is a genetically and phenotypically heterogeneous inherited disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22480464",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a genetically heterogeneous, autosomal recessive disorder characterized by pediatric bone marrow failure and congenital anomalies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20089964",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a heterogeneous disease associated with a bone marrow failure, cancer predisposition and hypersensitivity to DNA crosslinking agents.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25002988",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia is a genetically heterogeneous chromosomal instability syndrome, characterized by multiple congenital anomalies, progressive bone marrow failure, and a predisposition to malignancy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21438918",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a heterogeneous disease characterized by spontaneous chromosomal breaks and abnormal DNA repair.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23146055",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a genetically heterogeneous disease with at least eight genes on the basis of complementation groups (FAA to FAH).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9721219",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a clinically and genetically heterogeneous disorder.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11110674",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anaemia (FA) is a genetically heterogeneous disease with at least eight complementation groups (A-H).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11091222",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "FA is a genetically heterogeneous disease with at least seven genes so far identified.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12955722",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is an autosomal recessive rare disease characterized by progressive pancytopenia, congenital malformations and predisposition to acute myeloid leukemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15453041",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia is genetically heterogeneous, with at least eight complementation groups of FA (FAA to FAD2).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15453041",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA), an autosomal recessive disorder characterized by a progressive pancytopenia associated with congenital anomalies and high predisposition to malignancies, is a genetically and clinically heterogeneous disease",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10090479",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA), an autosomal recessive disorder characterized by a progressive pancytopenia associated with congenital anomalies and high predisposition to malignancies, is a genetically and clinically heterogeneous disease",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10807541",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The disease is clinically heterogeneous; eight different complementation groups (FA A-H) and, thus, genetic loci have been discovered",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9521584",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The hereditary genetic disorder Fanconi anemia (FA) belongs to the heterogeneous group of diseases associated with defective DNA damage repair",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19264559",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The clinical manifestations of FA are heterogeneous, but one common outcome in the majority of patients is the development of life-threatening hematologic disease",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9565158",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia is a genetically heterogeneous chromosomal breakage disorder exhibiting a high degree of clinical variability",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19367192",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a genetically heterogeneous chromosomal instability syndrome associated with multiple congenital abnormalities, aplastic anemia, and cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15657175",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a genetically heterogeneous autosomal recessive syndrome associated with chromosomal instability, hypersensitivity to DNA cross-linking agents, and predisposition to malignancy",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12552564",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a rare autosomal recessive disease characterized by progressive pancytopenia, congenital malformations, and predisposition to acute myeloid leukemia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12827451",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a heterogeneous disease characterized by spontaneous chromosomal breaks and abnormal DNA repair",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23146055",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a genetically and phenotypically heterogeneous recessive disorder characterized by diverse congenital malformations, progressive pancytopenia and predisposition to both hematologic malignancies and solid tumors",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24604962",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia is a genetically heterogeneous chromosomal instability syndrome, characterized by multiple congenital anomalies, progressive bone marrow failure, and a predisposition to malignancy",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21438918",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051856",
    "http://www.disease-ontology.org/api/metadata/DOID:13636",
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005199",
    "http://www.disease-ontology.org/api/metadata/DOID:1062"
  ],
  "exact_answer": "Yes"
}